METFORMIN AND INTESTINAL GLUCOSE HANDLING

被引:22
作者
BAILEY, CJ
机构
[1] Department of Pharmaceutical and Biological Sciences, Aston University, Birmingham
来源
DIABETES-METABOLISM REVIEWS | 1995年 / 11卷
关键词
D O I
10.1002/dmr.5610110505
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:S23 / S32
页数:10
相关论文
共 47 条
  • [1] Bailey CJ, Biguanides and NIDDM, Diabetes Care, 15, pp. 755-772, (1992)
  • [2] Bailey CJ, Metformin: an update, Gen Pharmacol, 24, pp. 1299-1309, (1993)
  • [3] Wilcock C, Bailey CJ, Reconsideration of inhibitory effect of metformin on intestinal glucose absorption, J Pharm Pharmacol, 43, pp. 120-121, (1991)
  • [4] Penicaud L, Hitier Y, Ferre P, Girard J, Hypoglycaemic effect of metformin in genetically obese (fa/fa) rats results from an increased utilization of blood glucose by intestine, Biochem J, 262, pp. 881-885, (1989)
  • [5] Wilcock C, Bailey CJ, Sites of metformin‐stimulated glucose metabolism, Biochem Pharmacol, 39, pp. 1831-1834, (1990)
  • [6] Bailey CJ, Wilcock C, Day C, Effect of metformin on glucose metabolism in the splanchnic bed, Br J Pharmacol, 105, pp. 1009-1015, (1992)
  • [7] Bailey CJ, Mynett KJ, Page T, Importance of the intestine as a site of metformin‐stimulated glucose utilization, Br J Pharmacol, 112, pp. 671-675, (1994)
  • [8] Vidon N, Chaussade S, Noel M, Franchisseur C, Huchet B, Bernier JJ, Metformin in the digestive tract, Diabetes Res Clin Pract, 4, pp. 223-229, (1988)
  • [9] Schafer G, Biguanides: a review of histroy, pharmacodynamics and therapy, Diabete Metab, 9, pp. 148-163, (1983)
  • [10] Noel M, Kinetic study of normal and sustained release dosage forms of metformin in normal subjects, Res Clin Forums, 1, pp. 35-50, (1979)